Pharma & Biotech
Pharmaxis transformational Bronchitol FDA approval extends cash runway to fund Myelofibrosis trial
Orgenesis leads the charge at an exciting time for cell and gene therapy
BioPorto focused on flagship NGAL acute kidney-injury test but also looking at coronavirus test
Only registered members can use this feature.
Copyright © Proactive Investors 2021.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.